Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $254.46 Analyst target: $263.60 Upside: 3.59%
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
See the full interactive analysis & chart →Informational only — not investment advice.